The clinical cure rate of early gallbladder cancer is generally high. Early gallbladder cancer usually only invades the mucous membrane and submucous layer of the gallbladder without breaking through the mucous layer, and there is no lymph node or distant metastasis, so only removal of the gallbladder is needed. Gallbladder cancer is usually evolved from untreated gallstones. It starts insidiously and its clinical manifestations include recurrent abdominal pain, right upper abdominal mass and progressive jaundice, as well as dyspepsia, cholangitis, and fatigue (poor appetite). Patients with previous gallstones, gallbladder polyps, cholecystitis and other diseases should be alerted to the occurrence of gallbladder cancer when the above symptoms occur. Radical resection surgery is the only possible cure for gallbladder cancer. However, the scope of surgical resection, whether it is combined with organ resection or combined with vascular resection and reconstruction, the scope of lymph node dissection, the treatment of extrahepatic bile ducts, and the treatment of cholangiocarcinoma of the cystic ducts need to be decided according to the condition. Early stage cholangiocarcinoma can be eradicated by cholecystectomy, but in middle and late stage, the chance of surgery is often lost or the scope of resection needs to be enlarged and combined with the resection of surrounding organs/tissues; and patients with advanced stage usually can only receive palliative surgical treatment. A study in China claims that the 1- and 3-year survival rates of gallbladder cancer are 71.6% and 45.8%, respectively. If gallbladder cancer is suspected or diagnosed, it is recommended to go to regular hospitals to evaluate the condition, follow the doctor’s instructions to cooperate with the treatment, and choose the appropriate treatment plan to improve the quality of survival and prolong the survival period.